Publications by authors named "Parinita Barman"
Atheroscler Plus
December 2024
Article Synopsis
- * A systematic review was conducted analyzing randomized controlled trials (RCTs) that assessed cardiovascular outcomes of non-statin LLTs, including bempedoic acid, alirocumab, evolocumab, ezetimibe, and inclisiran, with 2104 studies initially screened, ultimately identifying nine trials.
- * The results noted a fair-to-good quality of studies, indicating non-statin LLTs could be crucial for patients with C
